Polymorphisms in Catechol-O-Methyltransferase Modify Treatment Effects of Aspirin on Risk of Cardiovascular Disease

被引:32
作者
Hall, Kathryn T. [1 ,4 ]
Nelson, Christopher P. [5 ]
Davis, Roger B. [1 ,4 ]
Buring, Julie E. [2 ,4 ]
Kirsch, Irving [1 ,4 ,6 ]
Mittleman, Murray A. [4 ,7 ,8 ]
Loscalzo, Joseph [3 ,4 ]
Samani, Nilesh J. [5 ]
Ridker, Paul M. [2 ,4 ]
Kaptchuk, Ted J. [1 ,4 ]
Chasman, Daniel I. [2 ,4 ]
机构
[1] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Program Placebo Studies, Dept Med, Brookline, MA 02446 USA
[2] Brigham & Womens Hosp, Div Preventat Med, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Univ Leicester, Dept Cardiovasc Sci, Clin Res Ctr, Glenfield Gen Hosp, Leicester, Leics, England
[6] Univ Plymouth, Dept Psychol, Plymouth PL4 8AA, Devon, England
[7] Harvard Univ, Beth Israel Deaconess Med Ctr, Cardiovasc Epidemiol Res Unit, Div Cardiol,Med Sch, Boston, MA 02215 USA
[8] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
aspirin; catecholamines; vitamin E; GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; LOW-DOSE ASPIRIN; BLOOD-PRESSURE; VAL158MET POLYMORPHISM; PRIMARY PREVENTION; MESSENGER-RNA; VITAMIN-E; GENE; HOMOCYSTEINE;
D O I
10.1161/ATVBAHA.114.303845
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-Catechol-O-methyltransferase (COMT), a key enzyme in catecholamine metabolism, is implicated in cardiovascular, sympathetic, and endocrine pathways. This study aimed to confirm preliminary association of COMT genetic variation with incident cardiovascular disease (CVD). It further aimed to evaluate whether aspirin, a commonly used CVD prevention agent, modified the potential association of COMT with incident CVD. Approach and Results-We examined COMT polymorphism rs4680 (MAF [minor allele frequency], 0.47), encoding a nonsynonymous methionine-to-valine substitution, in the Women's Genome Health Study (WGHS), a large population-based cohort of women with randomized allocation to aspirin or vitamin E when compared with placebo and 10-year follow-up. Rs4680 effects were confirmed with COMT polymorphism rs4818 and also examined in Coronary ARtery DIsease Genome-wide Replication and Meta-analysis/The Coronary Artery Disease Genetics Consortium, consortia for genome-wide association studies of coronary artery disease. Among WGHS women allocated to placebo (135 events/n=5811), the rs4680 valine allele was protective against incident CVD relative to the methionine (hazard ratio [HR; 95% confidence interval {CI}], 0.66 [0.51-0.84]; P=0.0007); an association also observed in Coronary ARtery DIsease Genome-wide Replication and Meta-analysis and The Coronary Artery Disease Genetics Consortium (combined P=2.4x10(-5)). In the WGHS, the rs4680 association was abolished by randomized allocation to aspirin, such that valine/valine women experienced higher CVD rates with aspirin allocation when compared with placebo (HR [95% CI], 1.85 [1.05-3.25]; P=0.033), whereas methionine/methionine women experienced lower rates (HR [95% CI], 0.60 [0.39-0.93]; P=0.023). Allocation to vitamin E also conferred higher but nonsignificant CVD rates on valine/valine (HR [95% CI], 1.50 [0.83-2.70]; P=0.180) when compared with significantly lower rates on methionine/methionine (HR [95% CI], 0.53 [0.34-0.84]; P=0.006) women. Rs4818 results were similar. Conclusions-Common COMT polymorphisms were associated with incident CVD, and this association was modified by randomized allocation to aspirin or vitamin E. Replication of these findings is required.
引用
收藏
页码:2160 / 2167
页数:8
相关论文
共 37 条
  • [1] Catechol O-methyltransferase val158-met polymorphism is associated with abdominal obesity and blood pressure in men
    Annerbrink, Kristina
    Westberg, Lars
    Nilsson, Staffan
    Rosmond, Roland
    Holm, Goeran
    Eriksson, Elias
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2008, 57 (05): : 708 - 711
  • [2] [Anonymous], 1989, NEW ENGL J MED, V321, P129, DOI [DOI 10.1056/NEJM198907203210301, 10.1056/NEJM198907203210301.]
  • [3] The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications
    Bialecka, Monika
    Kurzawski, Mateusz
    Klodowska-Duda, Gabriela
    Opala, Grzegorz
    Tan, Eng-King
    Drozdzik, Marek
    [J]. PHARMACOGENETICS AND GENOMICS, 2008, 18 (09) : 815 - 821
  • [4] Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy
    Chasman, Daniel I.
    Shiffman, Dov
    Zee, Robert Y. L.
    Louie, Judy Z.
    Luke, May M.
    Rowland, Charles M.
    Catanese, Joseph J.
    Buring, Julie E.
    Devlin, James J.
    Ridker, Paul M.
    [J]. ATHEROSCLEROSIS, 2009, 203 (02) : 371 - 376
  • [5] Functional analysis of genetic variation in catechol-o-methyltransferase (COMT):: Effects on mRNA, protein, and enzyme activity in postmortem human brain
    Chen, JS
    Lipska, BK
    Halim, N
    Ma, QD
    Matsumoto, M
    Melhem, S
    Kolachana, BS
    Hyde, TM
    Herman, MM
    Apud, J
    Egan, MF
    Kleinman, JE
    Weinberger, DR
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 75 (05) : 807 - 821
  • [6] Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1
  • [7] Large-scale association analysis identifies new risk loci for coronary artery disease
    Deloukas, Panos
    Kanoni, Stavroula
    Willenborg, Christina
    Farrall, Martin
    Assimes, Themistocles L.
    Thompson, John R.
    Ingelsson, Erik
    Saleheen, Danish
    Erdmann, Jeanette
    Goldstein, Benjamin A.
    Stirrups, Kathleen
    Koenig, Inke R.
    Cazier, Jean-Baptiste
    Johansson, Asa
    Hall, Alistair S.
    Lee, Jong-Young
    Willer, Cristen J.
    Chambers, John C.
    Esko, Tonu
    Folkersen, Lasse
    Goel, Anuj
    Grundberg, Elin
    Havulinna, Aki S.
    Ho, Weang K.
    Hopewell, Jemma C.
    Eriksson, Niclas
    Kleber, Marcus E.
    Kristiansson, Kati
    Lundmark, Per
    Lyytikainen, Leo-Pekka
    Rafelt, Suzanne
    Shungin, Dmitry
    Strawbridge, Rona J.
    Thorleifsson, Gudmar
    Tikkanen, Emmi
    Van Zuydam, Natalie
    Voight, Benjamin F.
    Waite, Lindsay L.
    Zhang, Weihua
    Ziegler, Andreas
    Absher, Devin
    Altshuler, David
    Balmforth, Anthony J.
    Barroso, Ines
    Braund, Peter S.
    Burgdorf, Christof
    Claudi-Boehm, Simone
    Cox, David
    Dimitriou, Maria
    Do, Ron
    [J]. NATURE GENETICS, 2013, 45 (01) : 25 - U52
  • [8] Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
    Ehret, Georg B.
    Munroe, Patricia B.
    Rice, Kenneth M.
    Bochud, Murielle
    Johnson, Andrew D.
    Chasman, Daniel I.
    Smith, Albert V.
    Tobin, Martin D.
    Verwoert, Germaine C.
    Hwang, Shih-Jen
    Pihur, Vasyl
    Vollenweider, Peter
    O'Reilly, Paul F.
    Amin, Najaf
    Bragg-Gresham, Jennifer L.
    Teumer, Alexander
    Glazer, Nicole L.
    Launer, Lenore
    Zhao, Jing Hua
    Aulchenko, Yurii
    Heath, Simon
    Sober, Siim
    Parsa, Afshin
    Luan, Jian'an
    Arora, Pankaj
    Dehghan, Abbas
    Zhang, Feng
    Lucas, Gavin
    Hicks, Andrew A.
    Jackson, Anne U.
    Peden, John F.
    Tanaka, Toshiko
    Wild, Sarah H.
    Rudan, Igor
    Igl, Wilmar
    Milaneschi, Yuri
    Parker, Alex N.
    Fava, Cristiano
    Chambers, John C.
    Fox, Ervin R.
    Kumari, Meena
    Go, Min Jin
    van der Harst, Pim
    Kao, Wen Hong Linda
    Sjogren, Marketa
    Vinay, D. G.
    Alexander, Myriam
    Tabara, Yasuharu
    Shaw-Hawkins, Sue
    Whincup, Peter H.
    [J]. NATURE, 2011, 478 (7367) : 103 - 109
  • [9] Aspirin A Historical and Contemporary Therapeutic Overview
    Fuster, Valentin
    Sweeny, Joseph M.
    [J]. CIRCULATION, 2011, 123 (07) : 768 - 778
  • [10] Catechol-O-methyltransferase genotype is associated with plasma total homocysteine levels and may increase venous thrombosis risk
    Gellekink, Henkjan
    Muntjewerff, Jan-Willem
    Vermeulen, Sita H. H. M.
    Hermus, Ad R. M. M.
    Blom, Henk J.
    den Heijer, Martin
    [J]. THROMBOSIS AND HAEMOSTASIS, 2007, 98 (06) : 1226 - 1231